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ABSTRACT Proton binding plays a critical role in protein structure and function. We report pKa calculations for three
aspartates in two proteins, using a linear response approach, as well as a ‘‘standard’’ Poisson-Boltzmann approach. Averaging
over conformations from the two endpoints of the proton-binding reaction, the protein’s atomic degrees of freedom are explicitly
modeled. Treating macroscopically the protein’s electronic polarizability and the solvent, a meaningful model is obtained,
without adjustable parameters. It reproduces qualitatively the electrostatic potentials, proton-binding free energies, Marcus
reorganization free energies, and pKa shifts from explicit solvent molecular dynamics simulations, and the pKa shifts from
experiment. For thioredoxin Asp-26, which has a large pKa upshift, we correctly capture the balance between unfavorable
carboxylate desolvation and favorable interactions with a nearby lysine; similarly for RNase A Asp-14, which has a large pKa
downshift. For the unshifted thioredoxin Asp-20, desolvation by the protein cavity is overestimated by 2.9 pKa units; several
effects could explain this. ‘‘Standard’’ Poisson-Boltzmann methods sidestep this problem by using a large, ad hoc protein
dielectric; but protein charge-charge interactions are then incorrectly downscaled, giving an unbalanced description of the
reaction and a large error for the shifted pKa values of Asp-26 and Asp-14.
INTRODUCTION
The accurate determination of amino acid pKa values in
proteins is of fundamental interest in biophysical chemistry.
Knowledge of the pKa values of residues in the active site of
an enzyme helps identify potential proton donors and ac-
ceptors, and contributes to our understanding of the reaction
mechanism (Warshel, 1981; Raquet et al., 1997; Nielsen and
McCammon, 2003). The stability of proteins (Yang and
Honig, 1993; Swietnicki et al., 1997; Schaefer and Karplus,
1997; van Vlijmen et al., 1998; Morikis et al., 2001) and
protein-ligand complexes (Mackerell et al., 1995) depends on
the ionization state of titratable residues. pKa and redox
potential shifts provide information on the strength of
electrostatic interactions in the protein interior (Sternberg
et al., 1987; Varadarajan et al., 1989). Furthermore, theoret-
ical calculations of protein properties often depend strongly
on assumptions about the ionization state of titratable groups
(Simonson, 2003).
The ionization state of titratable amino acids in solution is
known from experiment. However, in a folded protein, the
pKa values can be shifted with respect to the solution values.
The shifts are caused by a combination of factors, including
the loss of interactions with the aqueous environment, inter-
actions with the protein’s charged and polar groups, and
structural reorganization of the protein in response to proton
binding (Warshel, 1987; Sham et al., 1997; Schutz and
Warshel, 2001; Simonson et al., 1999, 2004). These factors
compete with each other, making it difﬁcult to predict the
direction and magnitude of a particular pKa shift.
Theoretical methods to calculate protein pKa values have
been the focus of considerable efforts in the past two decades
(Warshel, 1981, 1987; Warshel et al., 1984; Warshel and
Russell, 1985; Bashford and Karplus, 1990; Gilson, 1993;
Yang and Honig, 1993; Antosiewicz et al., 1996; Beroza and
Case, 1996; Schaefer and Karplus, 1997; Schaefer et al.,
1998; Sham et al., 1997; Mehler and Guarnieri, 1999;
Georgescu et al., 2002; Nielsen and McCammon, 2003;
Simonson et al., 2004; Warwicker, 1999, 2004). Several
models that use very different assumptions (including
a ‘‘null’’ model) have had a roughly comparable success,
so that the underlying physics remains partly unclear and
controversial. A widely used approach treats the protein as
a low-dielectric cavity immersed in a high-dielectric solvent,
and determines the electrostatic free energy at various
ionization states by solving the Poisson-Boltzmann (PB)
equation (Warwicker and Watson, 1982; Davis and
McCammon, 1990; Honig and Nicholls, 1995).
In applications of these models to pKa calculations, it is
customary to treat the protein dielectric constant as an
adjustable parameter, which accounts for protein structural
reorganization upon a change in the ionization state (proton
binding or release), as well as for nonelectrostatic effects
such as van der Waals interactions, or the change in the
protein conformational entropy upon proton binding. The
meaning of the protein dielectric constant and many of the
approximations involved in continuum electrostatic calcu-
lations have been discussed in detail (Fro¨hlich, 1949;
Warshel et al., 1984; Sham et al., 1997, 1998; Schutz and
Warshel, 2001; Simonson, 2003; Simonson and Perahia,
1995a; Simonson et al., 1999; Smith et al., 1993; Krishtalik
et al., 1997; Nakamura, 1996). A difﬁculty is the consistent
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parameterization of these models. For example, most current
implementations use molecular mechanics charge sets, which
have been painstakingly parameterized to reproduce equi-
librium electrostatic potentials in combination with a protein
dielectric constant of 1 (Cornell et al., 1995; Jorgensen and
Tirado-Rives, 1988; Mackerell et al., 1998). This can pose
a problem for pKa calculations in which protein reorga-
nization plays a large role. The reorganization requires
a protein dielectric signiﬁcantly .1 (Fro¨hlich, 1949; Sham
et al., 1997; Smith et al., 1993; Simonson and Perahia,
1995a; Simonson et al., 1999), which is then inconsistent
with the charge set.
The idea of estimating pKa values by a linear response
approximation (LRA), using structures corresponding to the
states before and after ionization, was proposed by Warshel
(Lee et al., 1992, 1993; Sham et al., 1997). In this work, we
analyze several proton-binding reactions with a simple, LRA
method, which combines molecular dynamics simulations
with continuum electrostatics. Our method is equivalent to
the LRA method of Warshel, in that it expresses the pro-
tonation free energy as an electrostatic interaction energy
between the inserted charge and the permanent and induced
charges of the system, averaged over the equilibrium states
before and after proton binding (see Eq. 7). The LRA ex-
pression (Eq. 7) is derived from a two-step decomposition
of the charge insertion free energy, introduced originally by
Marcus (1956) in the context of electron transfer theory, and
applied recently to study dielectric relaxation in the enzyme
aspartyl-tRNA synthetase (Simonson et al., 1999; Archontis
and Simonson, 2001). The solvent and the electronic
polarization of the protein are treated by a dielectric con-
tinuum model (Warwicker and Watson, 1982), whereas the
atomic reorganization of the protein is described explicitly,
by averaging explicitly over conformations that are repre-
sentative of the two endpoint states (Lee et al., 1992, 1993;
Sham et al., 1997; Aqvist et al., 2002). We refer to the
method used in this work as PB/LRA. Closely related linear
response methods for free-energy calculations have been
introduced in the past (Del Buono et al., 1994; Aqvist et al.,
2002), and have been used successfully to calculate bind-
ing free energies in several receptor-ligand systems (Aqvist,
1991; Aqvist et al., 2002; Florian et al., 2002, 2003;
Jorgensen, 2004). This PB/LRA method was also employed
by Eberini et al. for pKa calculations in apo- and holo-
b-lactoglobulin (Eberini et al., 2004) (see below).
The optimum protein dielectric constant for continuum
pKa calculations depends on the details of the model. In
particular, it depends on which microscopic effects are re-
presented explicitly and which are represented implicitly
(Fro¨hlich, 1949; Lee et al., 1992, 1993; Sham et al., 1997;
Schutz and Warshel, 2001; Simonson, 2003; Simonson and
Perahia, 1995a; Eberini et al., 2004; Krishtalik et al., 1997).
By averaging over the two protein states before and after
protonation, we account explicitly for the atomic rearrange-
ments in response to proton binding. As a result, we expect
the best results to be obtained with a protein dielectric ep¼ 1
or 2, depending on whether electronic polarization is
considered explicitly or not (Fro¨hlich, 1949). Despite this
expectation, a larger dielectric constant may still be needed.
Eberini et al. employed the PB/LRAmethod and a continuum
model to calculate the pKa of a Glu residue in apo- and holo-
b-lactoglobulin (Eberini et al., 2004). Even though the
protein relaxation was explicitly accounted for by averaging
over the end states, it was found that ep  8 was needed to
reproduce the experimental pKa. Proton binding to this
particular Glu was associated with large conformational
rearrangements in the apo form of the enzyme and changes in
the solvent exposure of the titratable Glu. The authors spec-
ulated that the high dielectric constant might compensate for
limited sampling of the protein conformations in the two end
states and/or deviations from linear response. In the work
presented here, atomic reorganization of the protein is
modeled explicitly, whereas electronic polarization is mod-
eled implicitly. The best results are indeed obtained with
a protein dielectric ep of 1 or 2.
We use the PB/LRA method to compute the pKa shifts of
three carboxylates in two proteins. Two of the carboxylates
correspond to interior residues, with high pKa shifts; Asp-26
in thioredoxin, with a large pKa of 7.5 (Langstemo et al.,
1991) and Asp-14 in ribonuclease A, with a low pKa of 2.0
(Forsyth et al., 2002). As discussed by Warshel (Schutz and
Warshel, 2001), such interior residues represent the proper
benchmarks to test the accuracy of a pKa calculation. The
third carboxylate is the solvent-exposed Asp-20 in thio-
redoxin, with an unshifted pKa of 4.0 (Forsyth et al., 2002).
The chosen residues titrate approximately independently of
surrounding ionizable groups; i.e., the ionization state of the
other groups can be assumed ﬁxed whereas the carboxylate
under study binds a proton at a pH close to its pKa (Dillet
et al., 1998; Simonson et al., 2004); this simpliﬁes the
analysis.
The results are compared to experiment and to a recent cal-
culation of the same pKa shifts by molecular dynamics free
energy (MDFE) simulations in explicit solvent (Simonson
et al., 2004). Importantly, the comparison to MDFE includes
the electrostatic potentials, the reorganization free energies,
the protonation free energies, and the pKa shifts. Semi-
quantitative agreement with MDFE and with the experi-
mental pKa shifts is obtained using a low, physically
reasonable value of the protein dielectric constant (1 or 2).
In two out of three cases, the method actually yields better
agreement with experiment than do the MDFE simulations
(Simonson et al., 2004), probably because of a superior
treatment of electronic polarizability. Agreement with
experiment is rather poor for the unshifted Asp-20 case.
Nevertheless, in all three cases, the method yields insights
into the mechanisms that determine the pKa.
A detailed group decomposition of the free energy is used
to identify important contributions to the pKa shifts. We
also compute the reorganization, or relaxation free energies
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in response to ionization (the second step in the Marcus
free-energy decomposition) (Marcus, 1956; Krishtalik et al.,
1997; Sharp, 1998; Simonson et al., 1999; Archontis and
Simonson, 2001), even though they are not needed to
calculate the pKa values. The relaxation free energy and the
total free energy are linked (Simonson et al., 1999), so that the
relaxation data place a constraint on the protein dielectric
constant that can be used in a physically meaningful way for
the pKa values. This reduces our reliance on ﬁtting to the
experimental data and makes the model more predictive. We
show that, although the pKa values are best calculated with
a protein dielectric of 1 or 2, the protein reorganization free
energy is reproduced using a protein dielectric of 2–8. This
difference is not surprising, because the present pKa cal-
culations model the protein atomic reorganization explicitly,
whereas the reorganization calculations model it implicitly.
This result also agrees with our earlier studies (Simonson
et al., 1999; Archontis and Simonson, 2001) and those of
Krishtalik et al. (1997).
We also compare our results to a ‘‘standard’’ PB protocol
that uses a single protein endpoint structure (Bashford and
Karplus, 1990; Yang and Honig, 1993; Antosiewicz et al.,
1996; Raquet et al., 1997; Warwicker, 1999, 2004). Because
it does not include the protein relaxation explicitly, the
‘‘standard’’ method yields pKa shifts that depend strongly on
the structural model assumed for the protein. When a low
dielectric value is used for the protein (ep¼ 2–4), the method
fails in all three carboxylate calculations. When the protein
dielectric is increased to ep  20, the ‘‘standard’’ method
yields pKa shifts in reasonable agreement with experiment
for two cases, thanks to a fortunate compensation of errors,
even though this high dielectric value is shown to be un-
physical for these systems.
The following two sections present the theoretical deriva-
tion of the PB/LRA method and the details of the numerical
calculations. Results are presented next; the last section is
a discussion.
THEORY
Proton binding as a charge insertion process
The quantity of interest is the double free-energy difference DDG between
the protonation free energies when the side chain is part of the protein, and
when the same chemical group is alone in aqueous solution (Warshel, 1981,
1987; Bashford and Karplus, 1990). DDG is proportional to the difference
between the pKa of the side chain in the protein, pKa,prot, and that of the
chemical group in solution, pKa,model:
pKa;prot  pKa;model ¼ q
2:303 kT
DDG; (1)
where q is the charge of the ionized form of the titratable residue. The proton
binding is modeled in this work as the insertion of a set of point charges
fDqig onto selected aspartate side-chain atoms (Warshel, 1987; Bashford
and Karplus, 1990). The compound employed as a model of the chemical
group in solution is an aspartic acid molecule with N-acetyl and
N-methylamide blocking groups (Fig. 1 A). Its pKa is known experimentally
to be;4. We denote by ‘‘AspH’’/‘‘Asp’’ the protonated/unprotonated states
and by ‘‘midpoint’’ the ﬁctitious intermediate state where the Asp
carboxylate carries a net charge of 1/2. The partial charges used for
each charge state are shown in Fig. 1.
In the continuum dielectric framework used here, both the protein and the
surrounding aqueous solution will be treated as uniform dielectric media.
The titratable side chain, however, is treated as a cavity (Fig. 1 B). This is
consistent with our earlier work (Simonson et al., 1999; Archontis and
Simonson, 2001; Hoeﬁnger and Simonson, 2001) and with the continuum
models commonly used in quantum chemistry (Cramer and Truhlar, 1999).
It differs from the usual continuum approach, which embeds the side chain
directly within the protein dielectric. A side-chain cavity is essential to
obtain reasonable values for the protonation free energy (as compared to
MDFE for example). However, it has a rather small effect on the double free-
energy difference DDG between protein and model compound, which is the
experimentally relevant quantity. Indeed, the cavity contributions largely
cancel when the model compound result is subtracted, so that this treatment
FIGURE 1 (A) Schematic representation of the model compound
(2N-acetyl-1N-methyl-aspartic acid 1-amide), showing the partial charges
at the ionized (bottom values) and protonated state (top values). Charges
unaffected by ionization are not shown. (B) Schematic view of the titrating
side chain, surrounded by the protein (hatched) and solvent (shaded)
dielectric media. Fragment A corresponds to the inner, white region (see
‘‘Decomposing the free energy into two components’’).
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gives a similar result for DDG to the usual, ‘‘embedded side-chain’’
approach.
Decomposing the free energy into
two components
In the context of electron transfer theory,Marcus introduced a decomposition
of the charging free energy (Marcus, 1964) that is physically illuminating
and leads to a practical method for pKa calculation (Sham et al., 1997). The
transformation of the system from its initial, ‘‘reactant’’ state to its ﬁnal,
‘‘product’’ state can be decomposed into a ‘‘static’’ and a ‘‘relaxation’’ step
(Fig. 2) (Marcus, 1956). The free-energy change DG can be written
DG ¼ DGreacs 1DGreacr ; (2)
where DGreacs and DG
reac
r are the static and relaxation free energies, and the
superscript designates the starting, reactant state. In the case where a single
point charge is inserted at a position ‘‘0’’, the static term DGreacs is given by
DG
reac
s ¼ qV reac0 ; (3)
where Vreac0 is the equilibrium electrostatic potential at the insertion site ‘‘0’’
in the reactant state.
The reverse transformation can be carried out by inserting the charge q
into the ‘‘product state’’ at the same site. The corresponding free-energy
change DG9 can be written
DG9 ¼ DG ¼ DGprods 1DGprodr ; (4)
with
DG
prod
s ¼ qVprod0 : (5)
The continuum model is almost always assumed to be linear (Marcus,
1964; Bashford and Karplus, 1990; Honig and Nicholls, 1995; Roux and
Simonson, 1999). Under this assumption, the relaxation free energy is the
same in the reactant and product states (Sham et al., 1997; Simonson et al.,
1999; Simonson, 2002):
DG
reac
r ¼ DGprodr : (6)
Combining Eqs. 2, 4, and 6, we obtain for the total free-energy change:
DG ¼ 1
2
ðDGreacs 1DGprods Þ ¼
1
2
qðVprod0 1V reac0 Þ: (7)
Equation 7 is identical to the linear response approximation method of
Warshel (Lee et al., 1992, 1993), and is the basis of the linear interaction
energy method of Aqvist (e.g., Eq. 3 of Aqvist et al., 2002). It shows that the
total electrostatic free-energy change can be calculated by averaging the
interaction energies between the inserted charge and the permanent and
induced charges of the reactant and product states. It has been used for pKa
calculations in several proteins (Sham et al., 1997; Eberini et al., 2004), and
for binding free-energy calculations in several receptor-ligand systems
(Aqvist, 1991; Florian et al., 2002, 2003; Jorgensen, 2004). In earlier work,
we used it to study dielectric relaxation in response to charge insertion in the
active site of the enzyme aspartyl-tRNA synthetase (Simonson et al., 1999;
Archontis and Simonson, 2001).
Under the linear response approximation, the average of the reactant and
product static terms in Eq. 7 is exactly equal to the static term of the ﬁctitious
‘‘midpoint’’ state, in which a charge of q/2 has been introduced. Thus, we
can write
DG ¼ qVmidpoint0 : (8)
Generalizing these results to the insertion of several charges is
straightforward (see, e.g., Simonson et al., 1999 for details). The charges
are inserted onto a set of atoms that constitute a chemical fragment ‘‘A’’.
Denoting Dqi the charge inserted onto atom i, Eqs. 7 and 8 take the general
form
DG ¼ 1
2
+
i2A
DqiðV reaci 1Vprodi Þ; (9)
DG ¼ +
i2A
DqiV
midpoint
i ; (10)
where Vxxxi is the equilibrium electrostatic potential at the insertion site i in
the state ‘‘xxx’’. In this work, the Asp carboxylate protonation is modeled by
the introduction of a total charge q ¼ 11 onto the side-chain carboxylate
atoms (Fig. 1).
Equations 9 and 10 express the free-energy change DG in terms of the
equilibrium electrostatic potentials of the reactant, product, or midpoint states
at the charge insertion sites. To evaluate these potentials for a particular
protein structure, we solve the Poisson equation numerically, using dielectric
values eps ¼ e and ew¼ 80, respectively, for the protein and the solvent. The
potentials are averaged over several hundred protein structures, generated by
molecular dynamics (MD) simulations of the protein in a box of water, with
the aspartate of interest in the appropriate charge state (reactant, product,
or midpoint state; see Numerical Methods).
Importantly, the linear response assumption also leads to a direct relation
between the static and relaxation free-energy components (pointed out in
a slightly different context by Marcus, 1965; Muegge et al., 1997):
DG
reac
r ¼ DGprodr ¼
1
2
ðDGprods  DGreacs Þ: (11)
By comparing the relaxation free energy calculated directly (see below)
and by Eq. 11, we can verify the self-consistency of our analysis (Simonson
et al., 1999).
Selection of protein dielectric values
The pKa values calculated from Eqs. 9 and 10 depend strongly on the protein
dielectric constant, eps . As discussed by Warshel (Lee et al., 1992, 1993;
Sham et al., 1997; Schutz and Warshel, 2001) and others (Simonson, 2003;
Simonson and Perahia, 1995a; Eberini et al., 2004; Krishtalik et al., 1997),
the choice of eps depends, in turn, on the nature of the microscopic effects that
are explicitly modeled. By averaging over the two protein states, before and
after protonation, this PB/LRA method accounts explicitly for the atomic
rearrangements in response to proton binding. As a result, we expect the best
results will be obtained with a protein dielectric ep ¼ 1 or 2. Still, a larger
dielectric constant may be needed even in this case (see, e.g., Eberini et al.,
FIGURE 2 Schematic representation of the reactant and product free-
energy surfaces, showing the Marcus two-step reaction pathway. The curves
shown correspond to the Asp-20 free-energy components, obtained with
eps ¼ 2 (static) and epr ¼ 4 (relaxation).
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2004 where a PB/LRA method with esp ¼ 8 was used), to account for factors
such as limited sampling of the protein end states or deviations from linear
response.
In this work, we use four criteria to determine the optimum eps . The ﬁrst is
to reproduce approximately the known experimental pKa values. This is
satisﬁed with eps  1 2. The second is to choose a value consistent with the
molecular mechanics charge set used here (Mackerell et al., 1998). The
molecular mechanics charges are designed to reproduce the equilibrium
electrostatic potential with a dielectric constant of 1; the contribution of
electronic polarization is included implicitly in the partial charges. The
equilibrium structures used here were generated from MD simulations using
this same charge set and a protein dielectric of 1 (Simonson et al., 2004). The
implicit description can sometimes underestimate the effects of electronic
polarization; see Simonson et al. (2004) for an example. Therefore, a value
of eps between 1 and 2 appears plausible. The third criterion is to reproduce,
at least qualitatively, the individual protonation free energies obtained by
MDFE for the protein and the model compound. This is more stringent than
simply reproducing the difference DDG between the protein and the model
compound. The fourth criterion is a consistency condition that must be
obeyed by any linear response model, including a dielectric continuum
model. Indeed, the static and relaxation free-energy components are linked
directly by Eq. 11, and indirectly by Eqs. 2, 3, and 9. These relations place
constraints on the model, and help delimit which values of eps are physically
meaningful. This criterion has been mostly ignored in previous applications.
It requires that we consider in more detail the relaxation free-energy com-
ponent and that we distinguish between two different protein dielectric
constants (Krishtalik et al., 1997; Simonson et al., 1999).
More about the relaxation free energy
If the system obeys linear response, and if the electrostatic potentials are
available for either themidpoint state or for both endpoint states, the total free-
energy change DG can be obtained without ever calculating the relaxation
terms (they cancel in Eqs. 7–10). Nevertheless, their calculation helps
constrain the values of the dielectric constant eps that are physically
meaningful. They also provide valuable information about the dielectric
behavior of the system, because they directly measure its polarizability in
response to the charge insertion (Simonson et al., 1991, 1999; Simonson and
Perahia, 1995b;Archontis and Simonson, 2001; Simonson, 2002). Therefore,
we also evaluate the relaxation free energies for different ionization states of
the Asp side-chain carboxylate, using a range of values epr for the protein
dielectric.
In the dielectric continuum framework, relaxation in response to the
introduced charge is modeled by a redistribution of polarization charge at
the protein-solvent boundary, determined by the dielectric constants of the
solvent, ew¼ 80 and of the protein, epr 6¼ 1. For any state ‘‘xxx’’ (reactant or
product), one can show (Simonson et al., 1999) that the relaxation free energy
DGxxxr is identical to the usual Born self-energy of the inserted charges fDqig,
given by
DG
xxx
r ¼
1
2
+
i2A
DqiV
xxx;rx
i : (12)
Here, Vxxx;rxi is the reaction potential on the site i in state ‘‘xxx’’, due to
the charges fDqig.
Because the Poisson equation is linear, one might expect that our PB/
LRA model would obey linear response by construction, and DGreacr and
DGprodr would automatically agree. This is not necessarily true, because the
free energies depend on the protein structure, which could vary in a nonlinear
manner. However, in practice, it is true to a good approximation.
NUMERICAL METHODS
To obtain the electrostatic potentials appearing in Eqs. 9 and
10, we performed ﬁnite-difference Poisson calculations for
a large number of equilibrium structures (50–200) for each
charge state of the Asp side chain being considered. The
structures were taken from molecular dynamics simulations
of each charge state, described elsewhere (Simonson et al.,
2004). The protein and solvent were treated as two homo-
geneous dielectric media. The reacting side chain was treated
as a cavity (of dielectric unity). The protein-solvent and
protein-cavity dielectric boundaries were deﬁned by the
molecular surface of the protein and the reacting side chain,
respectively, constructed using atomic radii from the
CHARMM22 force ﬁeld, with the exception of the hydrogen
radii, which were set to 1.0 A˚ (Mohan et al., 1992; Simonson
and Bru¨nger, 1994). The probe sphere for the surface
construction was 2 A˚. With this probe radius, the protein has
no internal cavities (other than the reacting side-chain
cavity). The solvent dielectric was set to 80 (unless otherwise
mentioned). The value of the protein dielectric, eps , was
varied between 1 and 4. The permanent charges on the
protein atoms were taken from the CHARMM22 molecular
mechanics force ﬁeld (Mackerell et al., 1998). The ﬁnite-
difference Poisson equation was solved in two steps. The
ﬁrst step utilized a cubic-grid spacing of 0.8–1.0 A˚, and the
second, focusing step a spacing of 0.25–0.30 A˚. The
calculations were done partly with the UHBD program and
partly with the MEAD program (Madura et al., 1995;
Bashford, 1997). In particular, MEAD allows calculations
with three distinct dielectric media (cavity, protein, solvent).
When calculating the electrostatic potential Vxxxi at
a charge insertion site i (Eqs. 9 and 10), a contribution due
to preexisting charge at the same site is subtracted; this
‘‘self’’ contribution exactly cancels when the free energy for
the model compound is subtracted. For comparison to
molecular dynamics free-energy results, we also subtract
interactions between site i and protein atoms that are
separated from i by one or two covalent bonds (Mackerell
et al., 1998). This has essentially no effect on the computed
pKa shifts, but it allows a direct comparison with the MDFE
free-energy derivatives (below).
Unless otherwise mentioned, all the calculations were
done assuming zero ionic strength, so that in fact the Poisson
equation was solved, rather than the Poisson-Boltzmann
equation. Nevertheless, we always refer to the ‘‘PB/LRA’’
method. A subset of Asp-20 calculations was done with the
experimental ionic strength (100 mM monovalent salt
concentration) (Forsyth et al., 2002); this has a very small
effect on the free energies.
Calculations with some alternate solvent treatments are
reported in Supplementary Material. These include calcu-
lations involving 1–3 explicit water molecules, and calcu-
lations with different solvent dielectric constants.
RESULTS
We calculate the protonation free energies, relative to a model
aspartate compound in solution, of three aspartate side chains
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in two different proteins: Asp-26 in thioredoxin, Asp-14 in
RNase A, and Asp-20 in thioredoxin. The protonation free
energies have also been calculated by MDFE simulations
with an explicit solvent representation and two different
force ﬁelds (CHARMM and AMBER), as well as by MDFE
with two different implicit solvent (generalized Born) repre-
sentations. These calculations were presented in detail else-
where (Simonson et al., 2004). The CHARMM MDFE runs
employed the same atomic charges and radii used here.
To validate the method and the interpretation, we compare
the DDG from PB/LRA both to experiment and to the
CHARMM explicit solvent MDFE runs. In addition, we
compare the PB/LRA static free energies and protonation
free energies to the explicit solvent MDFE runs. We perform
two types of component analyses: group decompositions,
which reveal the most important stabilizing interactions, and
separate calculations of the relaxation free energies, which
provide a measure of the protein polarizability and allow
a consistency test of the continuum model. Finally, we
compare this PB/LRA method to a more ‘‘standard’’ PB
protocol that employs structures from a single endpoint of
the protonation reaction. We present the results for each
aspartate side chain separately. We begin by the model
compound, to illustrate the calculation of the static and
protonation free energies. Asp-26 is then discussed in detail,
and Asp-14 more brieﬂy. Asp-20, with its unshifted pKa,
presents unexpected difﬁculties and is described last.
The model compound
To determine the tendency of each Asp to be protonated, we
must ﬁrst consider the model compound in solution: an
aspartic acid molecule with N-acetyl and N-methylamide
blocking groups (Fig. 1), whose experimental pKa is 4.0
(Forsyth et al., 2002). To calculate the static terms entering in
the free-energy expressions, Eqs. 9 and 10, we need the
equilibrium electrostatic potentials Vxxxi at the charge in-
sertion sites (i¼Cb, Cg, Od1,Od2,Hd; Fig. 1). Calculations are
performed for three different equilibrium states: xxx ¼
reactant, product, and midpoint. Direct interaction energies
between the inserted chargesDqi and prior charges at the same
site i are omitted. We also report the corresponding static free
energies from the CHARMMMDFE runs. TheMDFE values
are identical to the free-energy derivatives (with respect to
a charging parameter l) reported in Table 1 of Simonson et al.
(2004). The signs correspond to the direction ASP/ASPH,
i.e., the direction of Asp protonation.
The static free energies are given in Table 1. With a solute
dielectric constant of eps ¼ 1, the static free-energy ranges
from 1139.6 (charged, reactant state) to 6.0 kcal/mol
(neutral, product state). Using the static free-energy values
and Eqs. 9 and 10, we can compute the protonation free
energy. The results are listed in Table 2, along with the result
from MDFE simulations of the same system with the
CHARMM force ﬁeld (Simonson et al., 2004). The pathways
‘‘2-point’’ and ‘‘1-point’’, respectively, are described by Eqs.
9 and 10. A compound pathway, represented by ‘‘3-point’’,
involves all three states (‘‘reactant’’, ‘‘midpoint’’, and ‘‘prod-
uct’’) and is described by Eq. 9. For the model compound, all
pathways yield the same value (166.5 kcal/mol), indicating
that linear response is accurately satisﬁed (as expected for
a smallmolecule in aqueous solution). This value is somewhat
more positive than the corresponding CHARMM MDFE
estimate (160.5 kcal/mol).
Setting eps ¼ 2, the solute backbone is treated as a bulk
dielectric medium, whose polarizability corresponds roughly
to the electronic polarizability of a peptide group. We con-
tinue to treat the titrating side-chain moiety as a cavity (with
a dielectric of one). With this scheme, the static free energies
shift slightly (Table 1). The protonation free energy (Table 2)
TABLE 1 Static free energies from PB/LRA and MDFE
Residue* State eps ¼ 1 eps ¼ 2 MDFEy
ASP 95.5(0.3) 116.8(0.3) 124.2(2.2)
Thioredoxin Asp-26 Midpoint 50.5(0.7) 59.5(0.4) 44.8(2.0)
ASPH 28.7(0.4) 10.7(0.3) 16.6(4.6)
ASP 130.0(0.8) 136.1(0.5) 142.3(2.4)
RNase A Asp-14 Midpoint 70.0(0.7) 67.4(0.3) 56.8(3.2)
ASPH 11.5(1.0) 0.3(0.6) 17.9(4.2)
ASP 131.9(0.5) 136.8(0.2) 143.5(0.8)
Thioredoxin Asp-20 Midpoint 60.5(0.3) 63.0(0.1) 57.0(1.2)
ASPH 9.3(0.3) 9.6(0.1) 19.0(0.4)
ASP 139.6(0.4) 143.3(0.2) 144.6(1.4)
Modelz Midpoint 66.4(0.1) 67.7(0.1) 58.4(0.8)
ASPH 6.0(0.2) 7.8(0.1) 19.3(1.4)
*Free energies in kcal/mol. The signs correspond to the ASP / ASPH
direction (protonation). The protein dielectric constant is eps ¼ 1 or 2. Mean
values over 100–200 MD structures are reported. The statistical uncertainty
of the PB static free energies (in parentheses) was determined by the
method of Flyvbjerg and Petersen (1989). A correction has been added to
the static terms to permit comparison with the MDFE derivatives (see text;
it is, respectively, 12.0, 1.0, and 4.1 kcal/mol at the protonated
(ASPH), midpoint, and charged (ASP) end state).
yFree-energy derivatives from a molecular dynamics free-energy simulation
(MDFE) starting from the ionized state ASP (‘‘backward’’ run); see Table 1
in (Simonson et al., 2004).
zThe model compound (Fig. 1) is an aspartic acid with N-acetyl and
N-methylamide blocking groups.
TABLE 2 Protonation free energies from PB/LRA and MDFE
Residue* Pathwayy eps ¼ 1 eps ¼ 2 MDFEz
2-point 62.1(0.3) 63.8(0.2) –
Thioredoxin Asp-26 1-point 50.5(0.7) 59.5(0.4) –
3-point 56.3(0.4) 61.7(0.2) 49.3(1.6)
RNase A Asp-14 3-point 70.3(0.5) 67.8(0.2) 59.4(2.0)
Thioredoxin Asp-20 3-point 60.8(0.2) 63.3(0.1) 59.6(0.6)
Model 3-point 66.5(0.1) 67.7(0.1) 60.5(0.6)
*Free energies in kcal/mol. The protein dielectric constant is eps ¼ 1 or 2.
Mean values over 100–200 MD structures are reported. Statistical
uncertainty in parentheses.
yThe ‘‘2-point’’, ‘‘1-point’’ values correspond, respectively, to Eqs. 9 and
10. The ‘‘3-point’’ values are obtained by applying Eq. 9 twice, to connect
the ‘‘reactant’’, ‘‘midpoint’’, and ‘‘product’’ states.
zFrom Simonson et al. (2004).
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becomes 167.7 kcal/mol, slightly more positive than before
(as expected, because of the additional polarizability). As
noted in Numerical Methods, treating the side chain as
a cavity is consistent with quantum chemistry practice, but
differs from the usual PB methods for proteins, which
‘‘embed’’ the side chain directly in the protein dielectric
medium. This cavity method is essential to obtain static free
energies and protonation free energies in fair agreement with
MDFE. It has only a small effect on the experimentally rele-
vant pKa shifts, however, because of cancellation between
the cavity contributions in the protein and the model com-
pound (see below).
Thioredoxin Asp-26
Static free energies
In Table 1, we report the static free energies for Asp-26 in
different charge states, using a protein dielectric eps of 1 or 2.
Because atomic reorganization is explicitly accounted for in
our method, eps ¼ 1 2 is the physically realistic range
(Fro¨hlich, 1949). When eps ¼ 2, the ionizable side chain
forms a small cavity within the protein.
With eps ¼ 1, the static free energy varies from 95.5 kcal/
mol (ionized state) to 28.7 kcal/mol (protonated state).
Agreement with the explicit solvent MDFE simulations is
fair. The larger value in the ionized state originates from
favorable interactions between the charged Asp-26 carbox-
ylate and nearby protein groups (particularly Lys-57), and
from solvent polarized by Asp-26 itself. In the protonated
state, the interactions between Asp-26 and the surrounding
groups are weaker and the static free-energy term is much
smaller.
Agreement between the midpoint value and the average of
the two endpoints is a necessary condition for the system to
obey linear response (Eq. 8). In the MD simulations of
thioredoxin presented in Simonson et al. (2004), it was
observed that the protonated Asp-26 x2 side chain occupies
two conformers (proton pointing into the pocket or toward the
solvent), which become equivalent at the ionized end state. As
shown in Simonson et al. (2004), the presence of the two
conformers leads to a signiﬁcant deviation from linear re-
sponse for the protein, although the solvent presumably still
responds as a linear medium. This LRA model allows for
a protein response that is piecewise linear, with different
slopes in the ﬁrst and second halves of the reaction (see
below).
With eps ¼ 2, the static terms vary between 116.8 kcal/mol
(ionized state) and 10.7 kcal/mol (protonated state), and the
midpoint value is 59.5 kcal/mol (Table 1).
Protonation free energy
Using the static free-energy values and Eqs. 9 and 10, we can
compute the protonation free energy for Asp-26. The results
are listed in Table 2, along with the result from MDFE simu-
lations of the same system with the CHARMM force ﬁeld
(Simonson et al., 2004).
The PB/LRA protonation free energies from the three
pathways differ somewhat, and are consistently more
negative than the corresponding CHARMM MDFE values.
If the response to ionization were rigorously linear, all the
pathways should give the same result. In fact, with eps ¼ 1, the
estimated free-energy change ranges from 50.5 to 62.1
kcal/mol (Table 2). The variability arises because the mid-
point static term is very different from the average over the
charged- and neutral-state static terms (see Table 1); this
indicates a nonlinearity in the protein dielectric response, al-
ready noted in the MDFE study (Simonson et al., 2004). We
recall that in this PB/LRA model, protein atomic reorgani-
zation is included explicitly by considering the two endpoint
states and the midpoint state. The ‘‘3-point’’ pathway, which
uses conformations for all three states, explicitly allows for
the possibility that the protein response may be piecewise
linear, with different slopes in the ﬁrst and second halves of
the reaction; this is exactly the behavior observed in the earlier
MDFE simulations. Therefore, this is presumably the most
reliable pathway for Asp-26, giving a protonation free energy
of 56.3 kcal/mol. Most of the discrepancy between PB/LRA
and MDFE will cancel when the model compound result is
subtracted (below).
With eps ¼ 1, all the protein reorganization is included in
the atomic rearrangements between the endpoint structures.
In fact, electronic polarizability may play a role in the pKa
shift. The CHARMM atomic charge set is meant to include
electronic polarization implicitly (Mackerell et al., 1998), in
a mean ﬁeld way. This average treatment may underestimate
local effects in some cases, so that a larger value of eps ¼ 2
may be appropriate. With eps ¼ 2, the Asp-26 protonation
free energy increases to 61.7 kcal/mol.
Relative protonation free energy and pKa shift
The protonation free energies with respect to the model
compound, and the corresponding pKa shifts are reported in
Table 3. With eps ¼ 1, and using the 3-point pathway (ex-
TABLE 3 PB/LRA free energies relative to the
model compound
Residue* eps ¼ 1 eps ¼ 2 MDFEy Exp.
Thioredoxin Asp-26 10.2(0.4) 6.0(0.2) 10.9(1.8) 4.8z
RNase A Asp14§ 4.9(0.5) 0.7(0.2) 0.0(2.1) .2.7{
Thioredoxin Asp-20 5.7(0.2) 4.4(0.1) 0.9(0.8) 0.0{
*Free energies in kcal/mol. The protein dielectric constant is eps ¼ 1 or 2.
Mean values over 100–200 MD structures are reported. Statistical
uncertainty in parentheses. All values correspond to the 3-point pathway.
yFrom Simonson et al. (2004).
zFrom Langstemo et al. (1991).
§A correction of 11.1 kcal/mol (eps ¼ 1) and 10.6 kcal/mol (eps ¼ 2) has
been added to the PB values, to take into account the protonation of other,
solvent-exposed carboxylates (see text).
{From Forsyth et al. (2002).
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pected to be the most reliable one), the protonation
free energy of Asp-26 relative to the model compound is
DDG ¼ 10.2 kcal/mol. This is higher (in absolute value)
than experiment, which gives 4.8 kcal/mol, but in very
good agreement with MDFE (especially the more reliable,
‘‘backward’’ MDFE run (Simonson et al., 2004)). Like PB/
LRA with eps ¼ 1, the MDFE method models atomic
reorganization of the protein explicitly, but has no explicit
electronic polarization.
With eps ¼ 2, electronic polarizability is explicitly in-
cluded. PB/LRA then gives DDG ¼ 6.0 kcal/mol, in good
agreement with experiment.
Group decomposition of the static free energy
The static free energy depends strongly on the state (pro-
tonated, ionized, or ‘‘midpoint’’). To understand this depen-
dency, we decompose the static terms into contributions from
selected protein residues (Table 4). Calculations were done
with eps ¼ 1.
The main difference between the protonated (ASPH) and
ionized (ASP) static terms arises from the Asp-26 self-
energy term (‘‘Asp-26a’’) and from nearby Lys-57. The
Asp-26a term corresponds to the reaction ﬁeld on Asp-26
due to solvent polarized by its own carboxylate. In agree-
ment with linear response, this term is proportional in each
state (ASPH, midpoint, ASP) to the Asp-26 charge in that
state. In contrast, the contribution of Lys-57 is fairly constant
in the neutral (13.2) and midpoint states (14.8 kcal/mol),
becoming much more positive (44.4 kcal/mol) in the charged
state. Lys-57 forms a salt bridge with Asp-26 in the charged
state; this interaction is completely absent in the protonated
and midpoint structures (see Figs. 4 and 5 in Simonson et al.,
2004).
RNase Asp-14
We have also calculated the protonation free energy for Asp-
14 in a different protein, ribonuclease A. The PB static free
energies are listed in Table 1. With eps ¼ 1, they vary from
130.0 kcal/mol (ionized state) to 7.7 kcal/mol (neutral state).
The midpoint value (70.0 kcal/mol) is close to the average
over the endpoints (68.9 kcal/mol), indicating that this
protonation reaction is well described by linear response.
The protonation free energy, consequently, has a very
small dependency on the choice of pathway (not shown).
With eps ¼ 1, the protonation free energy is estimated to be
between 70.0 and 70.7 kcal/mol, signiﬁcantly more positive
than the corresponding MDFE value (59.4 kcal/mol). The
3-point value is 70.3 kcal/mol (see Table 2). With eps ¼ 2,
the protonation free energy is 67.8 kcal/mol.
The experimental pKa for Asp-14 is 2, two units below the
model compound, and corresponding to an experimental rela-
tive protonation free energy of 2.7 kcal/mol. With eps ¼ 1,
the relative protonation free energy of Asp-14 is estimated
here to be 3.8 kcal/mol. With eps ¼ 2, it is 0.1 kcal/mol, in
poor agreement with experiment. However, the ribonuclease
simulations were done with all the protein carboxylates
ionized except for Asp-14 (Simonson et al., 2004). These
groups are solvent exposed and distant from Asp-14, and it
was assumed that their protonation state would not affect the
results strongly. In fact, implicit solvent (generalized Born)
simulations showed (Simonson et al., 2004) that when the
other carboxylates are protonated, the Asp-14 protonation
free-energy changes by 1.1 kcal/mol. Including this correc-
tion, with eps ¼ 1, the Asp-14 PB/LRA protonation free
energy increases to 4.9 kcal/mol (see Table 3). With eps ¼ 2,
it becomes 0.7 kcal/mol (the correction scales with eps ). The
MDFE calculation yielded a relative protonation free energy
of 0 kcal/mol, i.e., a zero pKa shift. The PB/LRA results with
either eps ¼ 1 or2 are somewhat more accurate. A dielectric
of eps  1:5 would give perfect agreement with experiment.
A group decomposition of the RNase Asp-14 free energies
is given in Table 5, with eps ¼ 1. The most important con-
tributions come from Asp-14, His-48, Arg-33, and Tyr-25. In
TABLE 4 Thioredoxin Asp-26 group contributions to the PB
static free energy
Group* ASPH Midpoint ASP
Asp-9 1.9(0.2) 2.1(0.3) 2.1(0.3)
Asp-43 2.4(1.4) 2.9(0.7) 1.2(0.5)
Lys-57 13.2(3.9) 14.8(3.9) 44.4(3.8)
Asp-26ay 5.3(0.5) 16.9(0.9) 30.5(1.3)
Asp-26bz 4.1(1.5) 6.6(1.4) 6.0(1.4)
Total 28.7 50.5 95.5
*Free energies in kcal/mol. The signs correspond to the ASP / ASPH
direction (protonation). Standard deviation along the MD trajectories in
parentheses.
yContribution due to the reaction ﬁeld induced by source charges at the
insertion sites.
zContribution from Asp-26, excluding the source charges.
TABLE 5 RNase Asp-14 group contributions to the PB static
free energy
Group* ASPH ASP
His-48 18.1(4.1) 29.7(5.7)
Arg-33 9.0(2.4) 21.9(4.8)
Tyr-25 3.6(3.7) 9.6(3.5)
His-12 1.2(0.5) 2.0(0.5)
Ser-16 1.0(0.9) 1.8(1.1)
Glu-49 1.5(0.3) 2.2(0.3)
Thr-82 1.9(0.4) 2.0(0.5)
Ala-19 2.3(0.7) 2.2(1.5)
Asp-14ay 1.2(1.2) 80.7(10.9)
Asp-14bz 2.5(1.1) 2.9(0.9)
Total 6.4 131.0
*Free energies in kcal/mol. The signs correspond to the ASP / ASPH
direction (protonation). Standard deviation along the MD trajectories in
parentheses.
yContribution due to the reaction ﬁeld induced by the source charges at the
insertion sites.
zContribution from Asp-14, excluding the source charges.
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the crystal structure (determined at a pH of 5.2), Asp-14 is
ionized and interacts with His-48 and Arg-33. In the MD
simulations, Asp-14 makes a hydrogen bond to His-48 and
forms a solvent-separated interaction with Arg-33. In accord
with these observations, the contributions of His-48 and
Arg-33 to thePBstatic termare signiﬁcant,withHis-48having
the larger value. Both contributions decrease by 12–13
kcal/mol in the neutral Asp-14 state, indicating a weak-
ening of interactions upon Asp-14 protonation.
Thioredoxin Asp-20
Asp-20 is completely exposed to the solvent and has an
experimental pKa shift of zero. This should be an ‘‘easy’’
case for pKa calculations. In fact, it poses speciﬁc problems.
The PB static free energies are listed in Table 1. With
eps ¼ 1, the static terms are 131.9 and 9.3 kcal/mol,
respectively, for the charged and neutral states. The midpoint
value (60.5 kcal/mol) is close to the average over the
endpoints (61.3 kcal/mol). With eps ¼ 2, the static free ener-
gies in the ionized and half-ionized states are more positive.
The qualitative agreement with the MDFE results is very
good.
Given the linear dependence of the PB static values on the
Asp-20 charge, the protonation free energy is almost inde-
pendent of the pathway (not shown). With eps ¼ 1, the
average over all pathways is DG ¼ 60.8 kcal/mol (Table 2).
The relative protonation free energy with respect to the
model is 5.7 kcal/mol (Table 3). The experimental result
is 0 kcal/mol. The corresponding estimate from MDFE is
0.9 kcal/mol. Thus, with eps ¼ 1, the PB/LRA method
incorrectly predicts a large upwards pKa shift.
To take into account the experimental ionic strength, 100
mM monovalent salt concentration, we also solved the
Poisson-Boltzmann equation for the protein in this case. This
increases the protonation free energy by ;0.5 kcal/mol,
improving the agreement with experiment very slightly.
Decomposition into contributions from all protein resi-
dues (Table 6) shows that the Asp-20 carboxylate itself
accounts almost entirely for the static PB free-energy values,
by polarizing the surrounding solvent. This is because Asp-
20 is extensively solvated, and its electrostatic interactions
with other protein residues are largely screened. This allows
us to explain the underestimated protonation free energy and
the incorrect pKa shift with e
p
s ¼ 1. Considering the mid-
point, for example, the static free energy of 60.5 kcal/mol is
5.9 kcal/mol weaker than for the model compound (Table 1).
This difference is about the same as the error in the pro-
tonation free energy. It indicates that the half-charged Asp-
20 carboxylate polarizes its surroundings more strongly in
the model compound than in the protein. Because the solvent
properties are the same in the two cases, it is the protein that
must account for the discrepancy. In fact, the protein polar-
ization by Asp-20 is underestimated. Indeed, with eps ¼ 1,
electronic polarization is underestimated (because the MD
charges only include it in a mean ﬁeld sense; Mackerell et al.,
1998). This effect was less evident for Asp-26 and Asp-14
(above), where the protein polarization was dominated by
atomic rearrangements.
Taking eps ¼ 2, the protonation free energy increases to
63.3 kcal/mol and DDG increases to 4.4 kcal/mol, or 3.9
kcal/mol, including the effect of ionic strength. This is still
rather far from the experimental value of zero.
These results raise the question: why does MDFE suc-
cessfully predict a small pKa shift for Asp-20? The MDFE
calculations use the same charges and the same conforma-
tions as the PB/LRA calculations; therefore, they must
underpolarize the protein to the same extent. To produce its
larger protonation free energy, MDFE must overpolarize the
solvent around thioredoxin, compared to the solvent around
the model compound. This compensation of errors between
protein and solvent polarization makes the MDFE calcula-
tion more robust than PB/LRA for this case.
This suggests that in the PB/LRA calculation, the macro-
scopic treatment of solvent polarization in the vicinity of
Asp-20 may be inaccurate. We discuss in Supplementary
Material some variants of the model that use slightly dif-
ferent solvent treatments. Some of these improve the agree-
ment with experiment slightly, but they do not change
the basic picture described here. Notice that for Asp-26,
MDFE with explicit solvent led to an even larger error of
6.1 kcal/mol (Simonson et al., 2004).
An obvious way to increase the Asp-20 protonation free
energy is to increase the protein dielectric eps .Warshel and co-
workers (Warshel et al., 1984) have shown that the use of
a large dielectric constant for charge-charge interactions is
expected to work well in cases of protein surface groups. This
has been empirically conﬁrmed by several pKa calculations
from various groups. However, we emphasize again that
because the present PB/LRA method treats protein reorgani-
zation explicitly, the physically realistic range is eps ¼ 1 2;
see Fro¨hlich for a deﬁnitive discussion (Fro¨hlich, 1949).
TABLE 6 Thioredoxin Asp-20 group contributions to the PB
static free energy
Group* ASPH ASP
Asp-20ay 6.3(1.3) 133.6(2.9)
Asp-20bz 0.3(0.7) 0.7(1.5)
Asp-15 0.6(0.1) 0.5(0.1)
Gly-21 0.8(0.2) 0.7(0.7)
Lys-82 0.6(0.2) 0.6(0.2)
Ala-19 0.3(0.7) 0.6(0.5)
Total 9.3 131.9
*Free energies in kcal/mol. The signs correspond to the ASP / ASPH
direction (protonation). Standard deviation along the MD trajectories in
parentheses.
yContribution due to the reaction ﬁeld induced by the source charges at the
insertion sites.
zContribution from Asp-20, excluding the source charges.
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Relaxation free energies
Following the two-step Marcus procedure, the charging free
energy can be decomposed into a static and a relaxation step;
see Eqs. 2 and 4. If linear response holds, the relaxation free
energies are independent of the state; they cancel from Eqs. 9
and 10, and are not needed for DG. Nevertheless, the
relaxation free energies are of interest. They help character-
ize the dielectric response to proton binding (Simonson and
Perahia, 1995b; Simonson et al., 1999; Archontis and
Simonson, 2001). In addition, the static and relaxation free
energies are linked (Eq. 11). Thus, the relaxation data serve
as an additional guide in choosing the optimum protein
dielectric constant for the pKa calculations.
To calculate the relaxation free energies, we perform PB
calculations for several values of the protein dielectric
constant epr and apply Eq. 12. The results are summarized in
Table 7. The relaxation values depend strongly on the protein
dielectric constant epr . As discussed above and elsewhere
(Simonson et al., 1999; Archontis and Simonson, 2001;
Krishtalik et al., 1997), different values will normally be
appropriate for eps and e
p
r . Optimal values can be determined
from the linear response consistency relation, Eq. 11. Mod-
erate values of epr  2 8 are optimal here. Larger values of
20 or 80, say, are not appropriate.
We ﬁrst discuss Asp-26. The relaxation free energy
depends very weakly on the charge state, in accord with linear
response (not shown). A dependency could arise if, e.g., the
location of the side chain in the protein, or the overall shape of
the protein dielectric cavity changed abruptly with the Asp
carboxylate charge state. The prediction of the linear response
formula (Eq. 11) is also shown in Table 7 for various values of
eps . When e
p
s ¼ 2 is used, consistency between the static and
relaxation terms is best satisﬁed with a relaxation dielectric
constant epr of;3 (values underlined). When e
p
s ¼ 1 is used,
consistency between the static and relaxation terms is best
satisﬁed with a lower relaxation dielectric constant epr of
;2. The difference is expected, because the ﬁrst scheme
corresponds to a protein that has explicit electronic polariz-
ability (eps ¼ 2), so that the relaxation free energy is enhanced.
In the case of RNase Asp-14, the optimum relaxation
dielectric constant is epr  3 when eps ¼ 1. When eps ¼ 2,
relaxation is enhanced, and the best epr is;6 8.
In the case of Asp-20, when eps ¼ 2 is used, consistency
between the static and relaxation terms is best satisﬁed with
a relaxation dielectric constant epr of;4. In this case, DGr
is very weakly sensitive to epr , because Asp-20 is solvent
exposed, and the relaxation is largely dominated by solvent.
The range of epr values found here for all three Asp side
chains, epr ¼ 2 8, is similar to that found for two positions
in the active site of the enzyme aspartyl-tRNA synthetase
(Simonson et al., 1999; Archontis and Simonson, 2001). It is
consistent with theoretical estimates of reorganization free
energies in cytochrome c (Simonson and Perahia, 1995b;
Simonson, 2002; Muegge et al., 1997), and with calculations
of the average dielectric constant of several proteins (King
et al., 1991; Smith et al., 1993; Simonson and Perahia,
1995a; Pitera et al., 2001; Simonson, 2003). It is also
consistent with the polarizability measured by several
experimental techniques, including dielectric dispersion by
dry protein powders (Bone and Pethig, 1985), Stokes shift
measurements for a probe bound in the active site of
chymotrypsin (Mertz and Krishtalik, 2000), and Stark shifts
of chromophores in the photosynthetic reaction center
(Steffen et al., 1994).
Comparison to a ‘‘standard’’ pKa protocol
It is important to compare our pKa results with a PB protocol
that is widely used for the calculation of pKa shifts (Bashford
and Karplus, 1990; Raquet et al., 1997; Yang and Honig,
1993; Antosiewicz et al., 1996; Warwicker, 1999, 2004). In
this ‘‘standard’’ protocol, a single protein structure is used,
corresponding to one or the other of the ionization states of
the residue of interest. For an Asp, a crystal structure with the
Asp side chain in the ionized state is typical. Because the
same atomic coordinates are used for both states, the protein
structural relaxation is not taken into account explicitly, but
only implicitly via the redistribution of polarization charge,
governed by the protein and solvent dielectric constants. To
obtain the protonation free energy of the same group in solu-
tion, analogous PB calculations are performed for a model
compound (Fig. 1), embedded in a high-dielectric medium
(the solvent).
TABLE 7 Relaxation free energies
epr * ð1=2ÞðDGASPHs  DGASPs Þy
1.0 2.0 3.0 4.0 8.0 eps ¼ 2 eps ¼ 1
Asp-26 15.3(1.9) 45.7(0.9) 55.9(0.5) 61.2(0.2) – 56.1 36.3
Asp-14 44.7(6.2) 60.4(3.6) – 68.3(1.8) 72.2(0.8) 71.0 62.3
Asp-20 72.8(1.7) 75.4(1.1) 75.8(0.0) 76.2(0.7) – 76.3 73.9
*Free energies in kcal/mol. The relaxation free energies were calculated by Eq. 12. Values underlined indicate which dielectric constants eps , e
p
r give
agreement (in the sense of Eq. 11, with ‘‘reac’’ [ ASP and ‘‘prod’’ [ ASPH) between static and relaxation free energies. Statistical uncertainty in
parentheses. Results for the two endpoints ASP, ASPH agree within the uncertainty, so that a single average value is reported for both states.
yA correction, added to the static terms of Table 1 to enable comparison with the MDFE derivatives, is omitted here (see footnote of Table 1). Thus, the
reported static term differences differ from the values that would be calculated from Table 1 (see text).
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We emphasize that this method can be implemented by
simply adding the static and relaxation free energies com-
puted here for either one of the endpoint structures. The con-
straint with the ‘‘standard’’ method is to use the same protein
dielectric for both components:
e
p ¼ eps ¼ epr ; (13)
(even though we have already seen that this is not physically
realistic with this CHARMM22 charge set). Some of the data
are available in Tables 1 and 7; to explore other dielectric
values, additional calculations were done. With this method,
we computed the pKa shifts of Asp-26, Asp-14, and Asp-20.
In each case, two sets of calculations were done using, re-
spectively, structures for the ionized or the protonated Asp
state. The structures are the same ones used for the PB/LRA
calculations above.
The results are given in Table 8. They vary with the pro-
tein dielectric constant as expected, but have also a striking
dependence on the structural model assumed for the protein.
Dielectric constants of 2–4 yield poor results in all cases. For
Asp-26 the relative free energies are 8 and 14 kcal/mol,
respectively, when protonated or ionized structures are used
with ep ¼ 4. The corresponding pKa shifts are 5.8 and 2.8;
the experimental value is 3.5. Increasing the protein di-
electric constant to 20, the pKa shifts become 1.4 and 0.7,
respectively; i.e., they converge toward zero, but deviate con-
siderably from the experimental result.
A similar dependency on the protein structure is observed
for Asp-14. With a protein dielectric of 4, the free energy is
7 kcal/mol when structures of the protonated endpoint are
used and 5 kcal/mol when structures of the ionized endpoint
are used. Increasing the protein dielectric to ep ¼ 20, the free
energies become 3 and 0, respectively. The experimental
result is for Asp-14 protonation is 2.7 kcal/mol (2 pKa
units).
In the case of the solvent-exposed Asp-20, the pKa shifts
computed with the two sets of structures are more similar.
Agreement with experiment is fair when a high protein dielec-
tric of 20 is used.
In the continuum dielectric framework used here, the
titratable side chain is treated as a cavitywithin the proteinme-
dium (Fig. 1 B). This differs from the usual approach, which
embeds the side chain directly within the protein dielectric. A
TABLE 8 pKa shifts with the ‘‘standard’’ PB protocol
ep ¼ 2* ep ¼ 4 ep ¼ 20 MDFEy Experiment
DGs, protonated state
z 8 8 8 19 –
DGs, ionized state
z 143 144 144 145 –
Model DGr 78 79 79 82§ –
DG 70/65{ 71/65 71/65 61 –
DGs, protonated state
z 11 2 6 17 –
DGs, ionized state
z 117 130 141 124 –
Thioredoxin DGr 46 61 75 70§ –
Asp-26 DG 57/71 63/69 69/66 49 –
DDGk 13/6 8/4 2/1 11 4.8
DpKa 9.6/4.3 5.8/2.8 1.4/0.7 8 3.5
DpKa** – 3.5/3.7 0.0/1.4 8 3.5
DGs, protonated state
z 0 4 7 18 –
DGs, ionized state
z 136 138 140 142 –
RNase A DGr 60 68 75 80§ –
Asp-14 DG 60/76 64/70 68/65 59 –
DDGk 10/11 7/5 3/0 0 .2.7
DpKa 7.2/8.0 5.0/3.6 2.2/0 0.0 ,2.0
DpKa** – 0.4/5.6 0.7/2.0 0.0 ,2.0
DGs, protonated state
z 10 9 9 19 –
DGs, ionized state
z 137 138 140 144 –
Thioredoxin DGr 75 76 77 81§ –
Asp-20 DG 65/62 67/62 68/63 60 –
DDGk 5/3 4/3 3/2 1 0.0
DpKa 3.6/2.2 2.9/2.2 2.2/1.4 0.7 0.0
DpKa** – 1.7/1.2 0.8/0.7 0.7 0.0
*Free energies in kcal/mol. The signs correspond to the direction ASP/ ASPH (protonation).
yFrom Simonson et al. (2004).
zResults averaged over 50–60 structures, taken from MD trajectories (with explicit solvent) of the corresponding state.
§From Eq. 10.
{Throughout the table, x/y denote results using structures from the protonated/ionized state.
kThe double differences were calculated using the same states (e.g., subtracting the protonated model/compound from the protonated protein value).
**The side chain is embedded directly in the protein medium; there is no side-chain cavity (see text).
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side-chain cavity is essential to obtain reasonable values for
the protonation free energy (compared toMDFE). Results are
also reported in Table 8 using an ‘‘embedded’’ side chain. As
expected, the effect of the side-chain cavity on the pKa shifts is
much smaller than on the absolute protonation free energies
(because the cavity contributions largely cancel when the
model compound result is subtracted). However, it is not
negligible, especially for Asp-14. Overall, the pKa shifts of
the ‘‘standard’’ protocol are slightly better without the side-
chain cavity (but the absolute ionization free energies are
far worse, as they scale approximately with the side-chain
dielectric value; not shown).
The poor performance of the standard protocol in the case
of thioredoxin Asp-26 is due, indirectly, to the large struc-
tural rearrangements of the protein upon ionization. As
discussed above, when Asp-26 is ionized, it forms a stable
salt bridge with Lys-57. In the ‘‘protonated’’ structures used
in the calculations of Table 8, the Lys-57–Asp-26 salt bridge
is absent, and the average Lys-57 Nz–Asp-26 Cg distance is
6.8 A˚. In these structures, the positive electrostatic potential
at the Asp-26 carboxylate is smaller, and elimination of the
Asp-26 charge is favored. Because the ‘‘standard’’ method
uses the same protein structure for the two charge states, the
protein relaxation upon ionization is modeled implicitly via
the dielectric constant. A rather large value is needed to
reﬂect the reorganization. But this large dielectric is not
compatible with the atomic charges employed; the result is
that the charge-charge interactions within the protein are not
accurately described, and the model is unbalanced. With this
method, the protonated endpoint structures predict that the
protonated state is stable; the ionized endpoint structures
predict that the ionized state is stable. The same behavior was
observed by Bashford and co-workers (Dillet et al., 1998),
and by Sharp and collaborators (Langsetmo et al., 1991).
In summary, the ‘‘standard’’ protocol cannot predict the
Asp-26 and Asp-14 pKa shifts with conﬁdence. Warshel and
co-workers (Warshel et al., 1984) have shown that any model
with a large dielectric constant for charge-charge interactions
is expected to work well in cases of surface groups. Indeed,
the standard protocol requires a very high dielectric constant
(.20) to reproduce the Asp-20 behavior. From our PB/LRA
analysis, this dielectric value is unphysical, because it is
consistent neither with the atomic charge set, nor with the
magnitude of dielectric relaxation in these systems, which
corresponds to epr ¼ 2 8 (Table 7). It reproduces the be-
havior ofAsp-20 because, as ep becomes large, the ‘‘standard’’
PB model becomes more and more like the ‘‘null’’ model
(which assumes all pKa shifts to be zero). A high dielectric
constant, has been used by several other workers as an
empirical attempt to compensate for factors that a more
‘‘physical’’ dielectric constant does not account for properly.
(Antosiewicz et al., 1994, 1996; Eberini et al., 2004).
The large dielectric constant reproduces the Asp-14
behavior because of a fortunate compensation of errors, by
underestimating the static free-energy component and over-
estimating the relaxation component. This compensation of
errors is expected to occur about half the time; viz., whenever
the relaxation and static free-energy components for a given
side chain have the opposite sign (see, e.g., the behavior of
Asp-26 when the protonated structures are used). When they
have the same sign, the ‘‘standard’’ protocol is likely to fail for
side chains with a signiﬁcantly shifted pKa. The sign of the
static component depends on which endpoint is used as the
reactant state, whereas the relaxation component is always
negative. Therefore, the ‘‘standard’’ protocol may appear
successful for a particular shifted pKa if onemakes a fortunate
choice of reactant state. It will be successful for unshifted pKa
values if ep is sufﬁciently large. In both cases, however, the
description of proton binding is at least partly unphysical.
DISCUSSION
Competing interactions determine the shifted
pKa values
The sign and magnitude of the pKa shift of a particular
titratable group is determined by the free energy to transfer it
into the low-dielectric protein cavity, and by its interactions
with polar residues in the protein (Sham et al., 1997;
Simonson et al., 2004). In this work, we have gained insight
into these competing factors for two buried and one solvent-
exposed titratable group, by extensively comparing implicit
(PB/LRA) and explicit (MDFE) treatments of selected
degrees of freedom.
The ﬁrst factor—side-chain desolvation—always opposes
ionization. It is closely related to the reaction ﬁeld con-
tribution to the static free energy; i.e., the ‘‘Asp-26a’’ entry
(respectively, Asp-14a, Asp-20a) in Tables 4–6. Its magni-
tude varies strongly with the extent of side-chain burial; e.g.,
from 30 kcal/mol for Asp-26 to 134 kcal/mol for Asp-20 (the
numbers correspond to protonation, i.e., the more positive
values favor ionization). The second factor may promote
(e.g., Asp-26, Asp-14), not affect (Asp-20), or disfavor
ionization, depending on the protein and the titratable group.
The relative magnitude of the two factors depends on the
particular case. In the systems studied here, Asp-26 has
a raised pKa because the desolvation free energy is not fully
compensated by the stabilizing interaction of ionized Asp-26
with Lys-57; Asp-14 has a lowered pKa thanks to its in-
teractions with positive amino acids (Table 5).
Assessment of PB/LRA
‘‘Standard’’ continuum methods for pKa values have faced
several major difﬁculties. The protein dielectric properties
vary from one titratable site to another, and are not accurately
described by a uniform dielectric constant. For example, the
three sites considered here correspond to relaxation dielectric
constants epr between 2 and 8. What is equally important is
that it is dangerous to use a molecular mechanics charge set,
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optimized for a protein dielectric of 1 or 2, to describe
a proton-binding reaction that involves signiﬁcant protein
reorganization. The most striking symptom of this problem
is the enormous dependency of the results, in unfavor-
able cases, on the structural model employed. Thus, for
thioredoxin Asp-26, structures corresponding to a protonated
Asp-26 or an ionized Asp give completely different results.
A third difﬁculty is the use of imperfect parameter sets;
indeed, PB calculations have a strong dependency on the
detailed atomic charges and radii. It is often possible to
‘‘ﬁx’’ these problems by adjusting the protein dielectric
constant and tolerating a few very poor predictions. The most
popular strategy is to choose a model close to the null model,
by setting the protein dielectric to a high value of 20, or even
80 (Warwicker, 1999). The model preserves the spatial
distribution of positive and negative side chains, but
purposely ignores the lower protein polarizability. With
this choice, a large protein relaxation and a large screening of
electrostatic interactions are built into the model. The risk is
then to obtain a physically unbalanced model, with a good
performance for solvent-exposed residues (where charge-
charge interactions are less signiﬁcant), and a limited
predictive capability for buried residues (Warshel et al.,
1984; Schutz and Warshel, 2001; Warwicker, 2004).
Of course, several more sophisticated PB approaches have
been developed that avoid some of these difﬁculties. A
microenvironment analysis of each titratable site can be used
to account for dielectric heterogeneity (Warwicker, 2004).
Several groups have included explicit conformational re-
organization of selected protein side chains in the model
(You and Bashford, 1995; Beroza and Case, 1996; Alexov
and Gunner, 1999; Georgescu et al., 2002). This has been
quite successful. Others have used MDFE with a generalized
Born solvent model (Simonson et al., 2004; Lee et al., 2003;
Feig and Brooks, 2004), or MD coupled with a continuum
electrostatics approach (Baptista et al., 1997; Dlugosz and
Antosiewicz, 2004). These latter methods represent atomic
reorganization of the protein explicitly, similar to the
PB/LRA method used here. PB/LRA accomplishes this by
averaging over structures that are representative of both
endpoint states (and possibly the midpoint state). This is
a difﬁcult and expensive operation, because we rarely have
structural models for both states ahead of time, so we must
generate them, e.g., by MD simulations. Electronic re-
organization is represented implicitly; partly through the
molecular mechanics charge sets, and partly by setting the
protein dielectric eps to a value between 1 and 2. A larger
value would imply a double counting of the protein’s atomic
reorganization, which is theoretically incorrect. Neverthe-
less, it may be needed in certain cases to account for effects
such as insufﬁcient sampling of the endpoint states, or
deviations from linear response; see, e.g., Eberini et al.
(2004).
With the PB/LRA method, we have studied three very
different Asp side chains: two buried ones, with an upward
(Asp-26) or a downward (Asp-14) pKa shift, and an exposed
one (Asp-20), with an unshifted pKa. In the two ‘‘difﬁcult’’
cases of partly buried amino acids, the titratable groups
interact strongly with proximal residues and ionization
causes signiﬁcant protein rearrangements. In these cases, PB/
LRA yields pKa shifts in rather good agreement with the
experimental values. The only parameter adjustment is the
setting of eps to a value between 1 and 2, the physically
acceptable range. A reasonable rule of thumb is probably to
take the average of the results with eps ¼ 1 and eps ¼ 2, and
view the half-difference as a fair uncertainty estimate. The
results calculated with this rule of thumb are summarized in
Table 9. This table also reports the predictions of the stan-
dard protocol (with ep ¼ 20) and the MDFE results.
Importantly, with the PB/LRA method, we also reproduce
qualitatively the electrostatic potentials, the protonation free
energies, and the Marcus reorganization free energies from
the explicit solvent MDFE simulations. This is considerably
more demanding than just ﬁtting pKa shifts, and it gives
conﬁdence that the PB/LRA model captures much of the
physics of proton binding and of the resulting dielectric
relaxation.
The unshifted carboxylate, Asp-20, turns out to be
surprisingly difﬁcult. The PB/LRA approach overestimates
the desolvation of Asp-20 by the protein by ;3.9 kcal/mol
(2.9 pKa units). This could be ‘‘corrected’’ by increasing the
protein dielectric to a value .2, as done in Eberini et al.
(2004). Unfortunately, this would amount to counting the
protein atomic reorganization twice. Another possibility is
TABLE 9 Summary of pKa shifts, calculated with PB/LRA, the ‘‘standard’’ PB protocol and MDFE
Standardz
Residue Pathway* PB/LRAy Cavity No cavity§ MDFE Experiment
Thioredoxin Asp-26 3-point 5.8(1.5) 1.4/0.7{ 0.0/1.4 7.8 3.5
RNase Asp-14 3-point 1.4(1.5) 2.2/0.0 0.7/2.0 0.0 ,2.0
Thioredoxin Asp-20 3-point 3.7(0.4) 2.2/1.4 0.8/0.7 0.6 0.0
*The pathways have been explained in Table 2 and refer to the PB/LRA entries.
yThe PB/LRA values correspond to averages of the results with eps ¼ 1 and eps ¼ 2.zUsing a protein dielectric of 20.
§The side chain is embedded directly in the protein medium (see ‘‘Comparison to a standard pKa protocol’’).
{Throughout the table, x/y denote results using structures from the protonated/ionized state.
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that solvent close to Asp-20 is more strongly ordered than in
the bulk, as was found for water close to lipid bilayers (Stern
and Feller, 2003). It may then be appropriate in some cases to
increase the local solvent dielectric. It is also possible that
charge rearrangements in the Asp-20 side chain (ignored
here) play a role; i.e., the carboxylate charge distribution
could be slightly different in the protein environment and in
the model compound. Alternatively, the atomic radii could
be dependent on the charge state, as observed for small
molecules in water (Bader and Berne, 1995). Finally, the
structures generated by MD do not allow for explicit
electronic polarizability, and the ‘‘a posteriori’’ correction
applied here may be insufﬁcient. Indeed, we ‘‘add back’’ the
polarizability by combining the MD conformations with
a protein dielectric constant of 2. But conformations that
are the most sensitive to polarizability are presumably un-
derrepresented from the outset. Reweighting the conforma-
tions with an umbrella sampling method might improve the
results (Ceccarelli and Marchi, 2003).
Comparison to a ‘‘standard’’ pKa protocol
The most widely used method for pKa calculations in
proteins is the ‘‘standard’’ protocol described above. It was
applied here to all three Asp side chains, using a wide range
of protein dielectric constants (1–20). It gives reasonable pKa
shifts for two out of three cases (Table 9) when a high protein
dielectric constant is used (ep ¼ 20).
It is striking that with the standard protocol, the residue
that requires the highest protein dielectric constant (Asp-20)
is precisely the one whose ionization produces the smallest
structural reorganization of the protein, as shown clearly by
the MDFE data (Simonson et al., 2004), the PB/LRA
component analysis (Table 6), and the relaxation analysis
(Table 7). We have shown that for Asp-20, the continuum
model overestimates the desolvation free energy in the
protein environment. In other words, the protein cavity has
too pronounced an effect, unless an artiﬁcially high protein
dielectric is used. A high ep reduces the desolvation penalty
by enhancing the relaxation free energy. It also downscales
incorrectly the interactions of the ionized side chain with
other protein residues. But for Asp-20, these interactions are
very weak in the ﬁrst place (see e.g., Table 6). With ep ¼ 80,
the desolvation penalty is zero and the model is very similar
to the null model (zero pKa shifts for all side chains).
As has been pointed out by Warshel (Warshel et al., 1984;
Schutz andWarshel, 2001), it is important to test the accuracy
of a pKa method by calculations on interesting cases, such as
partly buried active site residues with anomolous pKa values
(Asp-26, Asp-14). In these cases, interactions of the titratable
groups with other charged residues are expected to be both
large and strongly state dependent; that is, the titratable groups
and their environment reorganize substantially in response
to ionization. The reduction of the desolvation penalty must
be paid for by a loss of accuracy for the static free-energy
component. If ep is chosen .2, we have shown that
interactions between the ionized side chain and the rest of
the protein are incorrectly downscaled. A better route to
improve the ‘‘standard’’ method is to correct the unphysical
features of the model that are responsible for the exaggerated
desolvation. We have seen that a low protein dielectric
constant is physically correct for Asp-20; therefore, other
features of themodelmust be ﬁxed, such as theAsp-20 charge
distribution in the protein, the extent of solvent ordering, or
the statistical weights of the sampled conformations (Ceccar-
elli and Marchi, 2003). Alternatively, as a heuristic solution,
a high protein dielectric can be used for the relaxation free
energy; but it is crucial then to use a much lower protein
dielectric for the static free energy, so as not to ‘‘break’’ the
description of protein-protein interactions in the ‘‘difﬁcult’’
cases (Asp-26, Asp-14). The use of different protein dielectric
constants for the static and relaxation free-energy components
(Krishtalik et al., 1997; Sharp, 1998; Simonson et al., 1999;
Archontis and Simonson, 2001)may appear complicated. But
such a two-dielectric procedure would be a more physical
route than the ‘‘standard’’ one for the three Asp side chains
considered here.
CONCLUSION
Calculating and understanding pKa shifts in proteins remains
an important challenge for theoretical biophysics. The ion-
ization free energy of a titrating side chain depends on the
desolvation penalty to transfer a net charge from solution
into the protein cavity, and on the interactions between the
transferred charge and polar residues in the protein. The
relative magnitude of these two factors depends on the ge-
ometry of the particular protein, the location of the amino
acid with respect to the protein-solvent interface, and the
protein structural reorganization upon ionization. A theoret-
ical method has to account correctly for all these factors to be
accurate and yield correct insights.
In this work, we have used a dielectric continuum method
to study proton binding in three proteins. The method, PB/
LRA, uses linear response theory along with a decomposition
of the charge insertion free energy into static and relaxation
components, borrowed from electron transfer theory (Mar-
cus, 1956; Simonson et al., 1999). It accounts microscop-
ically for the protein atomic reorganization, by averaging the
static free-energy component over equilibrium structures of
the protein before and after proton binding, generated by MD
simulations. It accounts macroscopically for the protein’s
electronic polarizability.
The method is applied to three aspartate side chains in two
proteins. Two are buried in the protein interior, with sig-
niﬁcant pKa shifts; one is solvent exposed, with an unshifted
pKa. Themethod produces pKa shifts in reasonable agreement
with experiment in two out of three cases. Importantly, it also
reproduces semiquantitatively the electrostatic potentials, the
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protonation free energies, the Marcus reorganization free
energies, and the pKa shifts from MD with explicit solvent,
essentially without adjustable parameters. This gives conﬁ-
dence that the PB/LRA method captures much of the physics
of proton binding, and the resulting dielectric relaxation. For
the buried cases, the method captures correctly the balance
between protein reorganization, unfavorable desolvation, and
favorable interactions of the Asp carboxylate with proximal
protein residues. For the unshifted thioredoxin Asp-20,
desolvation is overestimated, possibly due to charge rear-
rangement on the Asp side chain, bias in the MD confor-
mations, or underestimated local solvent ordering.Morework
is needed to explore these factors.
Amore ‘‘standard’’ Poisson-Boltzmann pKa protocol does
not account explicitly for the protein structural reorganization.
When applied to the same systems, it yields pKa shifts that
depend strongly on the structural model assumed for the
protein. Furthermore, it requires a large protein dielectric
constant (20) to yield reasonable results in two out of three
cases. This large protein dielectric is unphysical because it is
inconsistent with the atomic charge set and the actual
magnitude of the protein dielectric relaxation.
The PB/LRA method is probably not suitable for large-
scale applications involving many titrating groups. Indeed, it
requires equilibrium structures for the protein before and
after proton binding, which is computationally demanding,
as most of the structures have to be generated by MD sim-
ulations. Nevertheless, for the analysis of electrostatic inter-
actions and dielectric relaxation in proteins, this method
represents a middle path between experiment, theory, ex-
plicit solvent simulations, and simpler continuum models.
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